The proteasome  by Pals-Rylaarsdam, Robin
Quick guide
The proteasome
Robin Pals-Rylaarsdam
What is it? The proteasome is a
multi-subunit protease complex that
degrades specifically targeted proteins.
Also known as¼“the molecular
chamber of doom” (see Hopkin K: 
J NIH Res 1997, 9:36–42). Do not call
the proteasome ‘the garbage disposal
unit of the cell’.
How are proteins directed to the
chamber of doom? The proteasome
recognizes and degrades proteins
that are tagged with ubiquitin chains.
Ubiquitin is a 76 amino-acid protein
that is covalently linked to lysine
residues of target proteins by
ubiquitinating enzymes. The process
is reversible; many deubiquitinating
enzymes have been identified.
How does it work? The proteasome
consists of a cylindrical 20 S catalytic
chamber (see Figure), capped on one
or both ends by a 19 S regulatory
complex. The regulatory complex
(which is made of at least 18
different subunits, six of which are
ATPases; not shown in the Figure)
recognizes ubiquitinated proteins and
is thought to drive their unfolding,
although the mechanism is not
understood. The proteins are
threaded through the small pores at
the ends of the catalytic chamber,
where three different protease
activities, located on the inside face
of the chamber, work to degrade
them. The resulting peptides exit
from the cylinder but it is not known
how this occurs. The proteasome also
has a deubiquitinating activity that
recycles the ubiquitin chains from
the degraded protein (see Figure).
What sorts of proteins are degraded?
All sorts, and the number identified
continues to grow. Some of the
proteins that are disposed of via the
proteasome are involved in cell-cycle
control, including cyclins, Pds1, Sic1,
Cdc5 and Cdc20. The stability of
transcriptional regulators, such as the
α2 repressor and HIF-1α, cytosolic
proteins like β-catenin, and
membrane proteins like the
epithelial sodium channel is
controlled by ubiquitin- and
proteasome-dependent proteolysis. 
A quality control system in the
endoplasmic reticulum exports
abnormal proteins to cytosolic
proteasomes for degradation. The
proteasome also processes antigens
for presentation — at the cell surface
— to the cells of the immune system.
Most likely to be mentioned by¼
Wolfgang Baumeister, Daniel Finley,
Alfred Goldberg, Mark Hochstrasser,
Martin Rechsteiner, Keiji Tanaka
and any cell-cycle researcher.
Can we do without it? No human
diseases are known to stem directly
from abnormal proteasome function
but there are syndromes associated
with abnormalities in regulated
proteolysis. Angelman’s Syndrome —
characterized by mental retardation
and seizures — is caused by a defect
in the ubiquitinating ligase UBE3A.
The most common mutation causing
cystic fibrosis inhibits transport of
the channel protein CFTR, resulting
in its proteasomal degradation.
Human papilloma virus, a common
cause of cervical cancer, accelerates
p53 degradation by targeting it to the
ubiquitination machinery. Protein
aggregates and neurofibrillary tangles
in several neurodegenerative
diseases contain ubiquitin and
components of the proteasome. The
proteasome is essential for viability
in yeast.
Is there anything else like it? There
are several large protease complexes
(among them, CIpP, bleomycin
hydrolase and tricorn proteases) that,
like the proteasome, contain a central
cavity with active sites that is
accessible via a pore. It’s not clear
how, if at all, their activities relate to
that of the proteasome.
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The eukaryotic 20 S catalytic particle is a
hollow cylinder made of four stacked rings of
seven subunits each. In eukaryotes, seven
different α subunits (red) and seven different
β subunits (blue) comprise each ring. The six
active sites for proteolysis (yellow) are located
inside the catalytic cylinder, three on each
β ring. The protein (purple) tagged with
ubiquitin (green) is unfolded into the chamber
where it is degraded into peptides.
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